| Literature DB >> 12164218 |
Abstract
In this study, eight original N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thiourea derivatives were synthesized and tested for antituberculosis activity. Antituberculosis activities of the synthesized compounds were screened in vitro using BACTEC 460 Radiometric System against Mycobacterium tuberculosis H37Rv at 6.25 microg/ml. The highest inhibition observed with the synthesized compounds is 67% for N-phenyl-N'-[4-(5-cyclohexylamino-1,3,4-thiadiazole-2-yl)phenyl]thiourea.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12164218 DOI: 10.1016/s0014-827x(02)01252-1
Source DB: PubMed Journal: Farmaco ISSN: 0014-827X